OpenSAFELY Vaccine Coverage Report
Pfizer / Priority Group 3
Data from combined, up to 2021-03-20.
| Vaccinated at 2021-03-20 (%) | Vaccinated at 2021-03-20 (n) | Population | Vaccinated at 2021-03-13 (%) | Vaccinated in past week (%) | ||
|---|---|---|---|---|---|---|
| Overall | - | 45.7% | 900,634 | 1,970,192 | 45.7% | 0.1% |
| Sex | Female | 45.6% | 478,716 | 1,049,629 | 45.6% | 0.1% |
| Male | 45.8% | 421,918 | 920,563 | 45.8% | 0.1% | |
| Ethnicity | White - British | 46.7% | 564,081 | 1,208,025 | 46.6% | 0.1% |
| White - Irish | 49.0% | 8,183 | 16,688 | 49.0% | 0.1% | |
| White - Any other White background | 42.7% | 18,417 | 43,120 | 42.7% | 0.0% | |
| Mixed - White and Black Caribbean | 35.4% | 763 | 2,156 | 35.4% | 0.0% | |
| Mixed - White and Black African | 32.5% | 371 | 1,141 | 32.5% | 0.0% | |
| Mixed - White and Asian | 44.6% | 581 | 1,302 | 44.6% | 0.0% | |
| Mixed - Any other mixed background | 41.0% | 931 | 2,268 | 41.0% | 0.0% | |
| Asian or Asian British - Indian | 49.4% | 12,628 | 25,543 | 49.4% | 0.1% | |
| Asian or Asian British - Pakistani | 36.2% | 3,829 | 10,584 | 36.2% | 0.0% | |
| Asian or Asian British - Bangladeshi | 40.4% | 1,176 | 2,912 | 40.4% | 0.0% | |
| Asian or Asian British - Any other Asian background | 46.1% | 5,278 | 11,438 | 46.1% | 0.1% | |
| Black or Black British - Caribbean | 35.7% | 4,074 | 11,424 | 35.6% | 0.1% | |
| Black or Black British - African | 29.9% | 2,401 | 8,036 | 29.9% | 0.0% | |
| Black or Black British - Any other Black background | 34.4% | 602 | 1,750 | 34.4% | 0.0% | |
| Other ethnic groups - Chinese | 39.4% | 1,253 | 3,178 | 39.4% | 0.0% | |
| Other ethnic groups - Any other ethnic group | 37.4% | 2,387 | 6,377 | 37.4% | 0.0% | |
| Patients with any other ethnicity code | 45.8% | 126,525 | 276,339 | 45.8% | 0.0% | |
| Ethnicity not stated | 42.8% | 5,019 | 11,718 | 42.8% | 0.0% | |
| Ethnicity not recorded | 43.5% | 142,002 | 326,088 | 43.5% | 0.0% | |
| Ethnicity (broad categories) | White | 46.6% | 590,702 | 1,267,847 | 46.5% | 0.1% |
| Mixed | 38.9% | 2,681 | 6,888 | 38.9% | 0.0% | |
| South Asian | 45.4% | 22,932 | 50,498 | 45.4% | 0.1% | |
| Black | 33.3% | 7,077 | 21,231 | 33.3% | 0.0% | |
| Other | 38.2% | 3,654 | 9,555 | 38.2% | 0.1% | |
| Unknown | 44.5% | 273,560 | 614,152 | 44.5% | 0.0% | |
| Index of Multiple Deprivation | 1 (most deprived) | 43.1% | 111,825 | 259,721 | 43.0% | 0.1% |
| 2 | 45.5% | 151,389 | 332,640 | 45.5% | 0.1% | |
| 3 | 46.0% | 192,787 | 419,454 | 45.9% | 0.1% | |
| 4 | 46.6% | 214,263 | 459,669 | 46.6% | 0.0% | |
| 5 (least deprived) | 46.3% | 223,909 | 483,392 | 46.3% | 0.0% | |
| Unknown | 42.1% | 6,433 | 15,288 | 42.1% | 0.0% | |
| Clinical Risk Groups | Patients in Any Clinical Risk Group | 46.0% | 532,854 | 1,159,410 | 45.9% | 0.1% |
| Patients with Immunosuppression | 47.2% | 40,446 | 85,743 | 47.1% | 0.1% | |
| Patients with CKD | 46.1% | 149,177 | 323,316 | 46.1% | 0.1% | |
| Patients who have Chronic Respiratory Disease | 45.3% | 101,500 | 224,168 | 45.2% | 0.1% | |
| Patients with Diabetes | 45.4% | 166,740 | 367,003 | 45.4% | 0.1% | |
| Patients with Chronic Liver disease | 46.5% | 24,248 | 52,178 | 46.4% | 0.1% | |
| Patients with CNS Disease (including Stroke/TIA) | 43.5% | 92,617 | 212,828 | 43.5% | 0.1% | |
| Patients with Chronic heart disease | 46.0% | 271,915 | 590,891 | 46.0% | 0.1% | |
| Patients with Asplenia or Dysfunction of the Spleen | 47.1% | 8,064 | 17,122 | 47.0% | 0.1% | |
| Patients with Wider Learning Disability | 31.6% | 735 | 2,324 | 31.6% | 0.0% | |
| Patients with Severe Mental Health | 37.0% | 5,824 | 15,750 | 36.9% | 0.0% | |
| Other Groups | Patients who are shielding (High Risk from COVID-19) | 44.5% | 136,850 | 307,188 | 44.5% | 0.1% |
| Patients with Morbid Obesity | 42.2% | 20,146 | 47,698 | 42.2% | 0.1% | |
| Patients who are pregnant | 40.6% | 91 | 224 | 40.6% | 0.0% |